Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 8/2020

01-08-2020 | Bone Infection | Brief Report

Misidentification of Cutibacterium namnetense as Cutibacterium acnes among clinical isolates by MALDI-TOF VitekMS: usefulness of gyrB sequencing and new player in bone infections

Authors: L. Ruffier d’Epenoux, N. Arshad, P. Bémer, M-E. Juvin, G. Le Gargasson, A. Guillouzouic, S. Corvec

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 8/2020

Login to get access

Abstract

The taxonomy modification of Propionibacterium sp. with the description of new species, especially Cutibacterium namnetense, raises the question of species distribution in routine clinical samples. We performed a retrospective study during 3 years before the implementation of MALDI-TOF. Two hundred sixty-nine isolates were included in the study. MALDI-TOF identification, 16S rRNA, and new developed gyrB partial sequencings were performed. The most representative species was C. acnes in 88% of the cases, regardless of the origin of the clinical sample. Eventually, we identified three C. namnetense strains, representing a 1.1% prevalence over the period of time, including two bone infections. MALDI-TOF databases should be regularly updated to incorporate new species. gyrB sequencing constitutes a both easy and relevant method to identify Cutibacterium sp. especially C. namnetense, a new player in bone infections.
Appendix
Available only for authorised users
Literature
6.
go back to reference Scholz CFP, Kilian M (2016) The natural history of cutaneous propionibacteria, and reclassification of selected species within the genus Propionibacterium to the proposed novel genera Acidipropionibacterium gen. nov., Cutibacterium gen. nov. and Pseudopropionibacterium gen. nov. Int J Syst Evol Microbiol 66:4422–4432. https://doi.org/10.1099/ijsem.0.001367 CrossRefPubMed Scholz CFP, Kilian M (2016) The natural history of cutaneous propionibacteria, and reclassification of selected species within the genus Propionibacterium to the proposed novel genera Acidipropionibacterium gen. nov., Cutibacterium gen. nov. and Pseudopropionibacterium gen. nov. Int J Syst Evol Microbiol 66:4422–4432. https://​doi.​org/​10.​1099/​ijsem.​0.​001367 CrossRefPubMed
7.
go back to reference Dekio I, Culak R, Misra R, Gaulton T, Fang M, Sakamoto M et al (2015) Dissecting the taxonomic heterogeneity within Propionibacterium acnes: proposal for Propionibacterium acnes subsp. acnes subsp. nov. and Propionibacterium acnes subsp. elongatum subsp. nov. Int J Syst Evol Microbiol 65:4776–4787. https://doi.org/10.1099/ijsem.0.000648 CrossRefPubMed Dekio I, Culak R, Misra R, Gaulton T, Fang M, Sakamoto M et al (2015) Dissecting the taxonomic heterogeneity within Propionibacterium acnes: proposal for Propionibacterium acnes subsp. acnes subsp. nov. and Propionibacterium acnes subsp. elongatum subsp. nov. Int J Syst Evol Microbiol 65:4776–4787. https://​doi.​org/​10.​1099/​ijsem.​0.​000648 CrossRefPubMed
9.
go back to reference Corvec S, Luchetta J, Aubin GG (2015) Letter to the editor: is hemolysis a clinical marker of Propionibacterium acnes orthopedic infection or a phylogenetic marker? Am J Orthop Belle Mead NJ 44:E61–E62PubMed Corvec S, Luchetta J, Aubin GG (2015) Letter to the editor: is hemolysis a clinical marker of Propionibacterium acnes orthopedic infection or a phylogenetic marker? Am J Orthop Belle Mead NJ 44:E61–E62PubMed
25.
Metadata
Title
Misidentification of Cutibacterium namnetense as Cutibacterium acnes among clinical isolates by MALDI-TOF VitekMS: usefulness of gyrB sequencing and new player in bone infections
Authors
L. Ruffier d’Epenoux
N. Arshad
P. Bémer
M-E. Juvin
G. Le Gargasson
A. Guillouzouic
S. Corvec
Publication date
01-08-2020
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 8/2020
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-020-03873-0

Other articles of this Issue 8/2020

European Journal of Clinical Microbiology & Infectious Diseases 8/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.